Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer - Socinski, M A; Schell, M J; Peterman, A (J Clin Oncol, 2002)
, et al.